| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.279 | 22.728 | 10.076 | 3.777 | 13.251 | 55.724 |
| Total Income - EUR | - | - | - | - | 3.506 | 22.837 | 10.078 | 3.777 | 13.253 | 55.729 |
| Total Expenses - EUR | - | - | - | - | 9.495 | 14.321 | 8.286 | 6.436 | 8.982 | 48.405 |
| Gross Profit/Loss - EUR | - | - | - | - | -5.990 | 8.516 | 1.792 | -2.659 | 4.271 | 7.324 |
| Net Profit/Loss - EUR | - | - | - | - | -6.093 | 7.968 | 1.719 | -2.756 | 3.620 | 5.410 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Bioactiv Line S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 149 | 122 | 119 | 0 | 0 | 28.666 |
| Current Assets | - | - | - | - | 21.805 | 12.862 | 14.015 | 12.532 | 16.346 | 29.503 |
| Inventories | - | - | - | - | 17.056 | 8.171 | 2.472 | 1.616 | 1.611 | 2.362 |
| Receivables | - | - | - | - | 3.434 | 4.525 | 11.502 | 10.895 | 11.239 | 27.055 |
| Cash | - | - | - | - | 1.315 | 165 | 41 | 22 | 3.496 | 86 |
| Shareholders Funds | - | - | - | - | -5.671 | 2.404 | 4.070 | 1.208 | 4.824 | 10.207 |
| Social Capital | - | - | - | - | 421 | 413 | 404 | 406 | 404 | 402 |
| Debts | - | - | - | - | 30.455 | 16.194 | 10.535 | 14.565 | 11.522 | 47.962 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Bioactiv Line S.r.l.